Tamer Group’s businesses include healthcare supply, manufacturing, consumer nutrition & wellness, logistics, e‑commerce, and IT solutions. It holds a 21% share of Saudi Arabia’s pharmaceutical‑distribution market. In December 2024, it unveiled plans for a Riyadh logistics complex and a specialized oncology & high‑potency drug facility in Jeddah, marking a total investment of over $266.7 million. In May 2024, Mölnlycke Health Care raised its stake in Tamer Mölnlycke Care from 33.3% to 60%.